Amino Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is L-TRYPTOPHAN, with a corresponding US DMF Number 8282.
Remarkably, this DMF maintains an Active status since its submission on October 24, 1989, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 01, 2021, and payment made on November 27, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II